Annual CFO:
-$112.16M+$134.90M(+54.60%)Summary
- As of today, ARQT annual cash from operations is -$112.16 million, with the most recent change of +$134.90 million (+54.60%) on December 31, 2024.
- During the last 3 years, ARQT annual cash from operations has risen by +$62.47 million (+35.77%).
- ARQT annual cash from operations is now -2871.07% below its all-time high of -$3.77 million, reached on December 31, 2017.
Performance
ARQT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$1.75M-$2.08M(-641.36%)Summary
- As of today, ARQT quarterly cash from operations is -$1.75 million, with the most recent change of -$2.08 million (-641.36%) on September 30, 2025.
- Over the past year, ARQT quarterly cash from operations has increased by +$32.93 million (+94.94%).
- ARQT quarterly cash from operations is now -641.36% below its all-time high of $324.00 thousand, reached on June 30, 2025.
Performance
ARQT Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$32.56M+$32.93M(+50.29%)Summary
- As of today, ARQT TTM cash from operations is -$32.56 million, with the most recent change of +$32.93 million (+50.29%) on September 30, 2025.
- Over the past year, ARQT TTM cash from operations has increased by +$135.10 million (+80.58%).
- ARQT TTM cash from operations is now -457.69% below its all-time high of -$5.84 million, reached on December 31, 2018.
Performance
ARQT TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ARQT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +54.6% | +94.9% | +80.6% |
| 3Y3 Years | +35.8% | +97.4% | +86.3% |
| 5Y5 Years | -161.8% | +94.9% | +67.1% |
ARQT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +56.5% | -641.4% | +97.8% | at high | +88.6% |
| 5Y | 5-Year | -161.8% | +56.5% | -641.4% | +97.8% | at high | +88.6% |
| All-Time | All-Time | -2871.1% | +56.5% | -641.4% | +97.8% | -457.7% | +88.6% |
ARQT Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$1.75M(-641.4%) | -$32.56M(+50.3%) |
| Jun 2025 | - | $324.00K(+101.1%) | -$65.49M(+41.0%) |
| Mar 2025 | - | -$30.38M(-3961.5%) | -$110.94M(+1.1%) |
| Dec 2024 | -$112.16M(+54.6%) | -$748.00K(+97.8%) | -$112.16M(+33.1%) |
| Sep 2024 | - | -$34.69M(+23.1%) | -$167.65M(+5.3%) |
| Jun 2024 | - | -$45.12M(-42.8%) | -$176.95M(+10.8%) |
| Mar 2024 | - | -$31.60M(+43.8%) | -$198.32M(+19.7%) |
| Dec 2023 | -$247.06M(+4.1%) | -$56.24M(-27.9%) | -$247.06M(+5.7%) |
| Sep 2023 | - | -$43.98M(+33.8%) | -$261.88M(+8.3%) |
| Jun 2023 | - | -$66.48M(+17.2%) | -$285.59M(-1.6%) |
| Mar 2023 | - | -$80.34M(-13.1%) | -$281.08M(-9.1%) |
| Dec 2022 | -$257.71M | -$71.06M(-5.0%) | -$257.71M(-8.1%) |
| Sep 2022 | - | -$67.69M(-9.2%) | -$238.36M(-12.7%) |
| Jun 2022 | - | -$61.98M(-8.8%) | -$211.55M(-14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$56.98M(-10.2%) | -$185.40M(-6.2%) |
| Dec 2021 | -$174.63M(-54.5%) | -$51.71M(-26.5%) | -$174.63M(-12.6%) |
| Sep 2021 | - | -$40.88M(-14.1%) | -$155.02M(-4.5%) |
| Jun 2021 | - | -$35.83M(+22.4%) | -$148.30M(-7.3%) |
| Mar 2021 | - | -$46.20M(-43.9%) | -$138.23M(-22.3%) |
| Dec 2020 | -$113.03M(-163.9%) | -$32.10M(+6.0%) | -$113.03M(-14.1%) |
| Sep 2020 | - | -$34.16M(-32.6%) | -$99.02M(-30.7%) |
| Jun 2020 | - | -$25.76M(-22.6%) | -$75.78M(-30.3%) |
| Mar 2020 | - | -$21.01M(-16.1%) | -$58.17M(-31.5%) |
| Dec 2019 | -$42.84M(-204.1%) | -$18.09M(-65.7%) | -$44.24M(-38.3%) |
| Sep 2019 | - | -$10.92M(-33.9%) | -$31.98M(-51.8%) |
| Jun 2019 | - | -$8.15M(-15.3%) | -$21.07M(-63.2%) |
| Mar 2019 | - | -$7.07M(-21.2%) | -$12.91M(-121.2%) |
| Dec 2018 | -$14.09M(-273.1%) | -$5.84M | -$5.84M |
| Dec 2017 | -$3.77M | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual cash from operations year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM cash from operations year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual cash from operations?
The current annual cash from operations of ARQT is -$112.16M
What is the all-time high annual cash from operations for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual cash from operations is -$3.77M
What is Arcutis Biotherapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, ARQT annual cash from operations has changed by +$134.90M (+54.60%)
What is Arcutis Biotherapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of ARQT is -$1.75M
What is the all-time high quarterly cash from operations for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly cash from operations is $324.00K
What is Arcutis Biotherapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, ARQT quarterly cash from operations has changed by +$32.93M (+94.94%)
What is Arcutis Biotherapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of ARQT is -$32.56M
What is the all-time high TTM cash from operations for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM cash from operations is -$5.84M
What is Arcutis Biotherapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, ARQT TTM cash from operations has changed by +$135.10M (+80.58%)